Loading clinical trials...
Loading clinical trials...
A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 10^5 and 10^7 CFU of SC599 Oral Vaccine, a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers
Conditions
Interventions
SC599
Locations
2
France
CIC de Vaccinologie Cochin Pasteur
Paris, France
Dept of Cellular and Molecular Medicine, St George's Hospital Vaccine Institute
London, United Kingdom
Start Date
May 1, 2005
Primary Completion Date
September 1, 2006
Completion Date
April 1, 2007
Last Updated
August 8, 2018
Lead Sponsor
Institut Pasteur
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions